WEKO3
アイテム
Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease
https://repo.qst.go.jp/records/84787
https://repo.qst.go.jp/records/847871c4fa6a3-649f-4437-a657-388c216feef0
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2021-12-15 | |||||
タイトル | ||||||
タイトル | Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Saito, Takashi
× Saito, Takashi× Ohnishi, Kayoko× Ishikawa, Hitoshi× Nakamura, Masatoshi× Hoshiai, Sodai× Numajiri, Haruko× Nemoto Murofushi, Keiko× Mizumoto, Masashi× Okumura, Toshiyuki× Sakurai, Hideyuki× Hitoshi, Ishikawa× Hideyuki, Sakurai |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Background/Aim: To evaluate the outcomes of proton beam therapy (PBT) for early-stage non-small cell lung cancer (NSCLC) in patients with interstitial lung disease (ILD). Patients and Methods: Between 2002 and 2017, 110 patients receiving hypofractionated PBT for cT1-2N0M0 NSCLC were reviewed. Results: Of the 110 patients, 17 were diagnosed with ILD. The median follow-up period was 37.8 months. No significant difference in the 1-year cumulative rate of grade ≥2 pneumonitis was observed between patients with and those without ILD (17.6% vs. 14.1%, p=0.708). The lung doses were significantly lower in patients with than in those without ILD among patients without grade ≥2 neumonitis. There were no significant differences in overall survival or local recurrence-free rates according to the presence of ILD. Conclusion: PBT appears to be a feasible and effective treatment for cT1-2N0M0 NSCLC in patients with ILD, but the lung dose should be strictly reduced. |
|||||
書誌情報 |
Anticancer research 巻 41, 号 11, p. 5635-5642, 発行日 2021-11 |
|||||
出版者 | ||||||
出版者 | International Institute of Anticancer Research | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0250-7005 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 34732436 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.21873/anticanres.15379 | |||||
関連サイト | ||||||
識別子タイプ | URI | |||||
関連識別子 | https://ar.iiarjournals.org/content/41/11/5635 |